ATE545423T1 - Mittel zur behandlung von lungenkrebs - Google Patents
Mittel zur behandlung von lungenkrebsInfo
- Publication number
- ATE545423T1 ATE545423T1 AT03712731T AT03712731T ATE545423T1 AT E545423 T1 ATE545423 T1 AT E545423T1 AT 03712731 T AT03712731 T AT 03712731T AT 03712731 T AT03712731 T AT 03712731T AT E545423 T1 ATE545423 T1 AT E545423T1
- Authority
- AT
- Austria
- Prior art keywords
- lung cancer
- agents
- treatment
- medicaments
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002074962 | 2002-03-18 | ||
PCT/JP2003/003206 WO2003077932A1 (fr) | 2002-03-18 | 2003-03-17 | Medicaments contre le cancer des poumons |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE545423T1 true ATE545423T1 (de) | 2012-03-15 |
Family
ID=28035342
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03712731T ATE545423T1 (de) | 2002-03-18 | 2003-03-17 | Mittel zur behandlung von lungenkrebs |
Country Status (10)
Country | Link |
---|---|
US (1) | US7091189B2 (de) |
EP (1) | EP1488795B1 (de) |
JP (2) | JP4786871B2 (de) |
KR (1) | KR100978705B1 (de) |
CN (2) | CN100400046C (de) |
AT (1) | ATE545423T1 (de) |
AU (1) | AU2003221036A1 (de) |
DK (1) | DK1488795T3 (de) |
ES (1) | ES2381408T3 (de) |
WO (1) | WO2003077932A1 (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11841159B2 (en) | 2002-03-06 | 2023-12-12 | John Chris Karamanos | Embedded heat exchanger with support mechanism |
USRE46708E1 (en) | 2002-03-06 | 2018-02-13 | John C. Karamanos | Embedded heat exchanger for heating, ventilation, and air conditioning (HVAC) systems and methods |
EP1488795B1 (de) | 2002-03-18 | 2012-02-15 | Dainippon Sumitomo Pharma Co., Ltd. | Mittel zur behandlung von lungenkrebs |
CN100438913C (zh) * | 2004-11-22 | 2008-12-03 | 山东蓝金生物工程有限公司 | 一种抗癌药物组合物 |
CA2711802C (en) | 2007-01-10 | 2016-08-16 | John C. Karamanos | Embedded heat exchanger for heating, ventilation, and air conditioning (hvac) systems and methods |
US8822153B2 (en) * | 2007-06-01 | 2014-09-02 | The University Of North Carolina At Chapel Hill | Molecular diagnosis and typing of lung cancer variants |
WO2009099649A1 (en) * | 2008-02-08 | 2009-08-13 | Poniard Pharmaceuticals, Inc. | Use of picoplatin and bevacizumab to treat colorectal cancer |
CN109453195B (zh) * | 2018-11-29 | 2021-04-20 | 湖南补天药业股份有限公司 | 一种用于抑制肿瘤细胞的药物组合物 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4315851A (en) * | 1978-12-29 | 1982-02-16 | Kureha Kagaku Kogyo Kabushiki Kaisha | Pharmaceutical composition having antitumor activity |
US5330744A (en) * | 1988-11-14 | 1994-07-19 | Sloan-Kettering Institute For Cancer Research | Method for increasing sensitivity to chemically induced terminal differentiation |
US6747055B1 (en) * | 1998-07-17 | 2004-06-08 | The United States Of America As Represented By The Department Of Health And Human Services | Water-soluble drugs and methods for their production |
TWI317285B (en) * | 2000-07-28 | 2009-11-21 | Dainippon Sumitomo Pharma Co | New use and kit for remedies for cancer |
CA2326004A1 (en) * | 2000-11-02 | 2002-05-02 | Richard E. Jones | Methods for treating cellular proliferative disorders |
KR101114790B1 (ko) | 2001-01-30 | 2012-02-28 | 다이닛본 스미토모 세이야꾸 가부시끼가이샤 | 폐암 치료제 |
EP1488795B1 (de) | 2002-03-18 | 2012-02-15 | Dainippon Sumitomo Pharma Co., Ltd. | Mittel zur behandlung von lungenkrebs |
-
2003
- 2003-03-17 EP EP03712731A patent/EP1488795B1/de not_active Expired - Lifetime
- 2003-03-17 WO PCT/JP2003/003206 patent/WO2003077932A1/ja active Application Filing
- 2003-03-17 AU AU2003221036A patent/AU2003221036A1/en not_active Abandoned
- 2003-03-17 ES ES03712731T patent/ES2381408T3/es not_active Expired - Lifetime
- 2003-03-17 DK DK03712731.3T patent/DK1488795T3/da active
- 2003-03-17 CN CNB038113473A patent/CN100400046C/zh not_active Expired - Fee Related
- 2003-03-17 KR KR1020047014610A patent/KR100978705B1/ko not_active IP Right Cessation
- 2003-03-17 AT AT03712731T patent/ATE545423T1/de active
- 2003-03-17 CN CN2007101966777A patent/CN101185652B/zh not_active Expired - Fee Related
- 2003-03-17 US US10/508,025 patent/US7091189B2/en not_active Expired - Fee Related
- 2003-03-17 JP JP2003575985A patent/JP4786871B2/ja not_active Expired - Lifetime
-
2011
- 2011-05-31 JP JP2011122274A patent/JP2011168621A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CN101185652B (zh) | 2010-12-08 |
WO2003077932A1 (fr) | 2003-09-25 |
CN101185652A (zh) | 2008-05-28 |
EP1488795B1 (de) | 2012-02-15 |
KR100978705B1 (ko) | 2010-08-30 |
KR20040097178A (ko) | 2004-11-17 |
CN100400046C (zh) | 2008-07-09 |
ES2381408T3 (es) | 2012-05-28 |
CN1652800A (zh) | 2005-08-10 |
US20050119196A1 (en) | 2005-06-02 |
US7091189B2 (en) | 2006-08-15 |
EP1488795A1 (de) | 2004-12-22 |
DK1488795T3 (da) | 2012-05-07 |
JPWO2003077932A1 (ja) | 2005-07-14 |
EP1488795A4 (de) | 2007-07-25 |
JP2011168621A (ja) | 2011-09-01 |
AU2003221036A1 (en) | 2003-09-29 |
JP4786871B2 (ja) | 2011-10-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004006842A3 (en) | Combinations of drugs for the treatment of neoplasms | |
DE60222137D1 (de) | Zuckerderivate von hydromorphon, dihydromorphin und dihydroisomorphin, zusammensetzungen davon und verwendung zur vorbeugung und behandlung von schmerzen | |
TW200518752A (en) | Combinations of drugs for the treatment of neoplasms | |
ATE307608T1 (de) | Kombination von doctaxel und rhumab her2 zür krebsbehandlung | |
BR0313282A (pt) | Composições de inibidor seletivo de ciclooxigenase-2 e um inibidor de anidrase carbÈnica para o tratamento de neoplasia | |
DK1373215T3 (da) | Gelanamycinderivater egnet til behandling af cancer | |
DE602004028841D1 (de) | Purin nucleoside für die behandlung von durch flavividrae verursachten krankheiten, einschliesslich hepatitis c | |
MX337511B (es) | Medicamentos y metodos para tratar cefaleas. | |
DE50311898D1 (de) | Fredericamycin-derivate als arzneimittel zur tumorbehandlung | |
IL171607A (en) | Use of botulinum toxin for the treatment of sinusitis-induced headaches | |
DE60234577D1 (de) | Pharmazeutische mischung zur behandlung von krebs, die dioxolan nukleosidanalogen enthält | |
HK1086186A1 (en) | Use of spongosine (2-methoxyadenosein) for preparing pharmaceutical for the treatment of pain | |
DE60324427D1 (de) | Verfahren zur modulation der tubulindeacetylase-aktivität | |
WO2003092617A3 (en) | Combinations for the treatment of inflammatory skin disorders | |
MXPA05004697A (es) | Soluciones farmaceuticas que comprenden un compuesto modafinil y uso para la fabricacion de un medicamento para tratar diferentes enfermedades. | |
ATE543492T1 (de) | Behandlung von lungenkrebs | |
WO2005011572A3 (en) | Combination of drugs for the treatment of neoplasms | |
DK1689404T3 (da) | Kombination af et-743 med 5-fluoracil-prodrugs til behandling af cancer | |
ATE545423T1 (de) | Mittel zur behandlung von lungenkrebs | |
MX2009003532A (es) | Tratamiento de hiperbilirrubinemia infantil utilizando bajas dosis de estansoporfina. | |
WO2004007676A3 (en) | Combination therapy for the treatment of neoplasms | |
BR9908190A (pt) | Processos para tratar a dor especìfica de fêmea em um paciente fêmea, e para tratar a dor crÈnica em um paciente | |
ATE345805T1 (de) | Calciumtrifluoracetat mit zytotoxischer wirkung | |
WO2002076393A3 (en) | Antiagionecic, antitumor, chemopreventative agents | |
WO2003079748A3 (en) | Potentiation of cancer therapies by znf217 inhibition |